Parents

Sign in to add mentor
Ronald M. Gerughty grad student 1976 MUSC
 (Thesis: "Mast cell : a participant in radiation pneumonitis.")
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Mont S, Davies SS, Roberts Second LJ, et al. (2016) Accumulation of isolevuglandin-modified protein in normal and fibrotic lung. Scientific Reports. 6: 24919
Travis EL, Rachakonda G, Zhou X, et al. (2011) NRF2 deficiency reduces life span of mice administered thoracic irradiation. Free Radical Biology & Medicine. 51: 1175-83
Barcellos-Hoff MH, Brenner DJ, Brooks AL, et al. (2011) Low-dose radiation knowledge worth the cost. Science (New York, N.Y.). 332: 305-6
Travis EL, Rachakonda G, Zhou X, et al. (2011) Abstract 5091: Increased susceptibility ofNrf2deficient mice to radiation-induced pulmonary fibrosis Cancer Research. 71: 5091-5091
Travis EL. (2007) Genetic susceptibility to late normal tissue injury. Seminars in Radiation Oncology. 17: 149-55
Guerrero T, Castillo R, Noyola-Martinez J, et al. (2007) Reduction of pulmonary compliance found with high-resolution computed tomography in irradiated mice. International Journal of Radiation Oncology, Biology, Physics. 67: 879-87
Hart J, Guerrero T, Johnson V, et al. (2007) Radiation Pneumonitis: Correlation of Clinical Toxicity With Pulmonary [18F]-Fluorodeoxyglucose Uptake Dose Response International Journal of Radiation Oncology*Biology*Physics. 69: S155
Cavanaugh D, Travis EL, Price RE, et al. (2006) Quantification of bleomycin-induced murine lung damage in vivo with micro-computed tomography. Academic Radiology. 13: 1505-12
Cavanaugh D, Travis EL, White R, et al. (2006) WE‐D‐330A‐04: Serial Flat Panel Computed Tomography Quantification of Bleomycin‐Induced Murine Lung Damage In Vivo Medical Physics. 33: 2240-2240
Komaki R, Chang JY, Wu X, et al. (2005) Mutagen sensitivity may predict lung protection by amifostine for patients with locally advanced non-small cell lung cancer treated by chemoradiotherapy. Seminars in Oncology. 32: S92-8
See more...